NANOVELOS - Drug Release Control Technology offered by NanoVelos demonstrates its power by transforming generics to super-generics via an innovative delivery system: they exhibit dramatically improved tumor targeting, thereby enhancing therapy efficacy while minimizing adverse effects on healthy tissues. Nanovelos offers also an adaptation of its proprietary drug delivery system for your anticancer drug. We can conjugate highly potent drugs that struggle to enter preclinical or clinical trials due to the intolerable toxicity or fast clearance.
View Top Employees from NanoVelos| Website | http://nanovelos.com/ |
| Revenue | $5 million |
| Employees | 5 (4 on RocketReach) |
| Founded | 2013 |
| Address | 36 Rakowiecka Rm 260, Warsaw, Masovian Voivodeship 02-532, PL |
| Technologies |
JavaScript,
HTML,
PHP
+5 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Delivery, Manufacturing, Administrative Services, Health Care, Pharmaceutical |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular NanoVelos employee's phone or email?
NanoVelos Questions
The NanoVelos annual revenue was $5 million in 2024.
Paweł Ciach is the Member of the Supervisory Board of NanoVelos.
4 people are employed at NanoVelos.
NanoVelos is based in Warsaw, Masovian Voivodeship.
The NAICS codes for NanoVelos are [32, 32541, 325, 3254].
The SIC codes for NanoVelos are [28, 283].
Top NanoVelos Employees
-
1
-
24
Related Companies
